These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 92577)

  • 41. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
    Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
    J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel early antigen associated with Epstein-Barr virus productive cycle.
    Freemer CS; Bertoni G; Takagi S; Sairenji T
    Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus.
    Sugden B; Metzenberg S
    J Virol; 1983 Jun; 46(3):800-7. PubMed ID: 6304342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycosylation pathways of two major Epstein-Barr virus membrane antigens.
    Strnad BC; Adams MR; Rabin H
    Virology; 1983 May; 127(1):168-76. PubMed ID: 6305014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.
    Edson CM; Thorley-Lawson DA
    J Virol; 1981 Jul; 39(1):172-84. PubMed ID: 6268807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation.
    Anisimová E; Prachová K; Roubal J; Vonka V
    Arch Virol; 1984; 81(3-4):223-37. PubMed ID: 6089703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unchanged expression of Epstein-Barr virus-determined nuclear antigen-1 in productive virus cycle.
    Nováková Z; Krchnák V; Roubal J
    Acta Virol; 1988 Jul; 32(4):349-52. PubMed ID: 2903640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus induced proteins V: comparison of EBV-specific polypeptides from different virus strains.
    Georg-Fries B; Mueller-Lantzsch N
    Med Microbiol Immunol; 1982; 171(1):11-21. PubMed ID: 6289060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoprecipitation of Epstein-Barr virus (EBV)-specific proteins by prelymphomatous and normal baboon sera containing antibodies reactive with EBV early antigen.
    Voevodin AF; Hirsch I
    Acta Virol; 1985 May; 29(3):242-6. PubMed ID: 2864826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracellular synthesis of Epstein-Barr virus membrane antigen gp350/220. Inhibitory effect of monensin on its expression.
    Bertoni G; Nguyen QV; Humphreys RE; Sairenji T
    Intervirology; 1989; 30(2):61-73. PubMed ID: 2542183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis.
    Catalano MA; Carson DA; Slovin SF; Richman DD; Vaughan JH
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5825-8. PubMed ID: 230491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
    Zhu XX; Zeng Y; Wolf H
    Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia.
    Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE
    Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
    Takimoto T; Sato H; Ogura H
    Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
    Hewetson JF; Levine PH; Neubauer RH; Rabin H
    Int J Cancer; 1982 Nov; 30(5):581-5. PubMed ID: 6295966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IgM antibodies to Epstein-Barr virus-associated membrane antigen in sera of infectious mononucleosis patients.
    Harada M; Sairenji T; Takaki K; Hinuma Y
    Microbiol Immunol; 1980; 24(2):123-32. PubMed ID: 6247623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells.
    Fresen KO; Cho MS; zur Hausen H
    Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
    Fujiwara S; Takada K; Yano S; Osato T
    Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.
    Kurakata S; Ramos OF; Klein G; Klein E
    Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.